Front Row Advisors LLC Helius Medical Technologies, Inc. Transaction History

Front Row Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 22, 2023	BUY	$0.23 - $0.41 $0 - $0	1 New	1 $0
Q4 2022 Feb 15, 2023	BUY	$0.22 - $14.5 $0 - $0	0 New	0 $0
Q2 2022 Aug 15, 2022	SELL	$1.14 - $3.48 $1 - $3	-1 Closed	0 $0
Q2 2021 Aug 23, 2021	BUY	$13.28 - $18.45 $13 - $18	1 New	1 $0

Ticker HSDT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,197,200
Market Cap $13.8M
Description
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gai...

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Front Row Advisors LLC with notifications on news.